Siegfried Haas
Friedrich-Ebert-Krankenhaus(DE)
Publications by Year
Research Areas
Cancer Genomics and Diagnostics, Lung Cancer Treatments and Mutations, Genetic factors in colorectal cancer, Colorectal Cancer Treatments and Studies, Cancer Immunotherapy and Biomarkers
Most-Cited Works
- → Genomic and transcriptomic changes complement each other in the pathogenesis of sporadic Burkitt lymphoma(2019)151 cited
- → DNA methylome analysis in Burkitt and follicular lymphomas identifies differentially methylated regions linked to somatic mutation and transcriptional control(2015)150 cited
- → The genomic and transcriptional landscape of primary central nervous system lymphoma(2022)135 cited
- → MYC/MIZ1-dependent gene repression inversely coordinates the circadian clock with cell cycle and proliferation(2016)124 cited
- → MINCR is a MYC-induced lncRNA able to modulate MYC’s transcriptional network in Burkitt lymphoma cells(2015)100 cited
- → Mutational mechanisms shaping the coding and noncoding genome of germinal center derived B-cell lymphomas(2021)56 cited
- → Alterations of microRNA and microRNA-regulated messenger RNA expression in germinal center B-cell lymphomas determined by integrative sequencing analysis(2016)49 cited
- → Nintedanib Plus Docetaxel After Progression on Immune Checkpoint Inhibitor Therapy: Insights from VARGADO, A Prospective Study in Patients with Lung Adenocarcinoma(2019)25 cited
- → Real-World Efficacy of Nintedanib Plus Docetaxel After Progression on Immune Checkpoint Inhibitors: Results From the Ongoing, Non-interventional VARGADO Study(2022)17 cited
- → Impact of sex on the efficacy and safety of panitumumab plus fluorouracil and folinic acid versus fluorouracil and folinic acid alone as maintenance therapy in RAS WT metastatic colorectal cancer (mCRC). Subgroup analysis of the PanaMa-study (AIO-KRK-0212)(2023)9 cited